Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial

Journal Article Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator‐blinded trial Get access A. Taieb, A. Taieb Service de Dermatologie et Dermatologie Pédiatrique Hôpital Saint‐André 1 rue Jean Burguet 33075 Bordeaux Cedex France Correspondence Alain Taieb. E‐mail: alain.taieb@chu-bordeaux.fr Search for other works by this author on: Oxford Academic Google Scholar J.P. Ortonne, J.P. Ortonne Service de Dermatologie Hôpital Archet 2 Nice France Search for other works by this author on: Oxford Academic Google Scholar T. Ruzicka, T. Ruzicka Department of Dermatology and Allergy Ludwig‐Maximilian Universität Munich Germany Search for other works by this author on: Oxford Academic Google Scholar J. Roszkiewicz, J. Roszkiewicz Department of Dermatology Medical University of Gdansk Poland Gdansk Poland Search for other works by this author on: Oxford Academic Google Scholar J. Berth‐Jones, J. Berth‐Jones Department of Dermatology Dermatology Clinical Research Unit Nuneaton U.K Search for other works by this author on: Oxford Academic Google Scholar M.H. Peirone, M.H. Peirone Galderma R&D Sophia Antipolis France Search for other works by this author on: Oxford Academic Google Scholar J. Jacovella, J. Jacovella Galderma R&D Sophia Antipolis France Search for other works by this author on: Oxford Academic Google Scholar on behalf of the Ivermectin Phase III study group on behalf of the Ivermectin Phase III study group Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 172, Issue 4, 1 April 2015, Pages 1103–1110, https://doi.org/10.1111/bjd.13408 Published: 01 April 2015